13F Holdings
中文EN

ICLR ICON PLC

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1060955

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.4%
TTM net income YoY5.0%
TTM EPS YoY25.8%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR-2.8%

Margins

Gross margin23.5%
Operating margin5.3%
Net margin5.4%
FCF margin10.3%
EBITDA margin9.7%

Returns

ROE5.0%
ROA2.8%
ROIC (approx.)3.0%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets43.8%
Debt / equity0.37x
Current ratio1.32x
Interest coverage2.06x

Cash quality & payout

Operating cash flow / net income2.29x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$8.25B$8.19B$8.05B$7.74B$5.48B
Cost of revenue$6.08B$5.82B$5.71B$5.53B$3.97B
Gross profit$2.18B$2.37B$2.35B$2.21B$1.51B
SG&A expense$780.14M$728.35M$768.56M$778.75M$585.33M
Operating income$442.85M$1.03B$904.66M$795.24M$378.53M
Interest expense$197.49M$237.24M$336.70M$229.73M$182.42M
Pretax income$252.47M$803.76M$572.98M$567.85M$196.68M
Income tax$23.13M$64.63M$18.39M$59.41M$41.33M
Net income$229.34M$739.13M$554.21M$505.30M$153.19M
EBITDA$825.84M$1.52B$1.49B$1.36B$693.52M
EPS (basic)2.928.966.756.202.28
EPS (diluted)2.908.906.706.132.25
Weighted avg. shares (diluted)78.97M83.03M82.72M82.47M68.07M
Balance sheet
Cash & equivalents$647.29M$538.78M$378.10M$288.77M$752.21M
Short-term investments$0$0$1.95M$1.71M$1.71M
Receivables$1.47B$1.39B$1.76B$1.73B$1.34B
Inventory————$5.80M
Current assets$3.50B$3.28B$3.29B$3.23B$2.94B
PP&E, net$395.72M$382.88M$361.18M$350.32M$336.44M
Goodwill$8.73B$9.05B$9.02B$8.97B$9.04B
Intangibles$3.25B$3.56B$3.86B$4.28B$4.71B
Total assets$16.27B$16.63B$16.86B$17.19B$17.39B
Current liabilities$3.20B$2.64B$2.73B$2.69B$2.48B
Long-term debt$2.87B$3.40B$3.67B$4.60B$5.38B
Total debt$2.87B$3.40B$3.67B$4.60B$5.38B
Total liabilities$7.08B$7.19B$7.65B$8.69B$9.32B
Shareholders' equity$9.19B$9.44B$9.21B$8.53B$8.07B
Net debt$2.23B$2.86B$3.29B$4.31B$4.63B
Shares outstanding76.57M80.76M82.50M81.72M81.55M
Cash flow statement
Operating cash flow$1.04B$1.29B$1.16B$563.32M$829.14M
Capital expenditure$174.21M$168.06M$140.69M$142.16M$93.75M
Free cash flow$861.99M$1.12B$1.02B$421.15M$735.39M
Investing cash flow-$187.53M-$266.79M-$226.65M-$145.87M-$6.02B
Financing cash flow-$771.26M-$837.18M-$844.04M-$864.17M$5.11B
Depreciation & amortization$383.00M$488.50M$585.95M$569.51M$314.99M
Stock-based compensation$102.04M$45.87M$55.67M$70.52M$133.84M
Share buybacks$750.00M$500.00M$0$99.98M$0

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.